medozil 10 mg
medochemie ltd., cyprus - donepezil - 06 - psychostimulantia (nootropne lieČ., analeptika)
converide 300 mg/25 mg
medochemie ltd., cyprus - irbesartan a diuretiká - 58 - hypotensiva
converide 300 mg/12,5 mg
medochemie ltd., cyprus - irbesartan a diuretiká - 58 - hypotensiva
mantomed 20 mg
medochemie ltd., cyprus - memantín - 06 - psychostimulantia (nootropne lieČ., analeptika)
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastické činidlá - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).